Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 2856 for cancer

Edit search filters
  1. A Study To Compare Mobile Health And Social Media Physical Activity Intervention Among Adolescent And Young Adult Childhood Cancer Survivors

    Rochester, MN

  2. Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy In Black Men With Locally Advanced, Biochemically Recurrent And Metastatic Prostate Cancer

    Jacksonville, FL

  3. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors

    Scottsdale/Phoenix, AZ

  4. Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study Of DF9001 In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Study Of IBI3020 Treatment In Participants With Late-Stage Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate Non-Operative Management And Early Response Assessment In Rectal Cancer

    Rochester, MN

  8. Study To Test The Safety And Tolerability Of PF-07257876 In Participants With Selected Advanced Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Orexin Receptor Antagonist In Hospitalized Patients With Cancer To Prevent Delirium

    Rochester, MN

.

Mayo Clinic Footer